Poisons board issues warning on counterfeit Herceptin 440mg in Kenyan market
The Pharmacy and Poisons Board (PPB) has issued an alert over a suspicious batch of counterfeit breast cancer treatment drug, Herceptin 440mg (Trastuzumab 440mg), detected in the market. According to the board, the product batch is claimed to be manufactured…